3.8 Article

Quantification of peripheral blood CD34+ cells prior to stem cell harvesting by leukapheresis: a single center experience

期刊

HEMATOLOGY TRANSFUSION AND CELL THERAPY
卷 40, 期 3, 页码 213-218

出版社

ELSEVIER
DOI: 10.1016/j.htct.2018.01.002

关键词

Transplantation; Apheresis; CD34(+) progenitor cells; Flow cytometry

资金

  1. Fundo de Incentivo a Pesquisa e Eventos (FIPE-HCPA)

向作者/读者索取更多资源

Background: Due to laboratory logistic issues, our center has traditionally scheduled peripheral blood stem cell harvests based on timing from the start of mobilization. This has proved to be useful in some cases, but also resulted in many fruitless harvests due to poor mobilization. In order to improve the efficiency of collections and compare the effectiveness of peripheral blood CD34(+) cells as a predictor with data from other reports, this study analyzed the implementation of this routine. Methods: Peripheral blood and leukapheresis samples were quantified by flow cytometry and the association between these parameters was assessed. Results: Sixty-six consecutive leukapheresis samples were collected from 34 patients after the collection of peripheral blood samples for CD34(+) quantification. A moderate positive correlation was observed between peripheral blood CD34(+) cell count and total CD34(+) cell count/kg (r = 0.596; p-value <0.001). A multivariable regression model also confirmed this association and allowed the estimation that for every increase in five CD34(+) cells/mu L in the peripheral blood, a mean increase of 0.38 x 10(6) CD34(+) cells/kg could be predicted. Demographic characteristics, baseline comorbidities and mobilization regimen did not influence final CD34(+) cell count in this sample. Conclusions: As observed in other centers, quantification of peripheral blood CD34(+) progenitor cells is a strong predictor of effectiveness to guide stem cell harvesting. Due to the results of this study, a modification in the peripheral blood stem cell harvesting logistics was implemented at our center in order to incorporate this routine. (C) 2018 Associagdo Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Editora Ltda.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

3.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据